Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

0(0%)

Results Posted

25%(1 trials)

Phase Distribution

Ph phase_4

60%

Ph not_applicable

40%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 4Post-market surveillance

3(60.0%)

N/ANon-phased studies

2(40.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(4)

Other(1)

Detailed Status

Completed4

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 43 (60.0%)

N/A2 (40.0%)

Trials by Status

completed480%

unknown120%

Recent Activity

0 active trials

Showing 5 of 5

completedphase_4

Assessment and Augmentation of Lip Appearance in Specific Study Populations

NCT04839692

completednot_applicable

Histology and Ultrasound Pilot Study of HA Gels Adipose Tissue

NCT02868749

unknownnot_applicable

A Slit Face Trial Using Micro-injections of Transparent Hyaluronic Acid Gel for Rejuvenation of the Cheek

NCT02679924

completedphase_4

Hyaluronic Acid in Papillary Reconstruction

NCT02876276

completedphase_4

Non-inferiority of Belotero® Basic Versus Juvéderm® Ultra 3

NCT01305187

Clinical Trials (5)

Showing 5 of 5 trials

NCT04839692Phase 4

Assessment and Augmentation of Lip Appearance in Specific Study Populations

Completed

NCT02868749Not Applicable

Histology and Ultrasound Pilot Study of HA Gels Adipose Tissue

Completed

NCT02679924Not Applicable

A Slit Face Trial Using Micro-injections of Transparent Hyaluronic Acid Gel for Rejuvenation of the Cheek

Unknown

NCT02876276Phase 4

Hyaluronic Acid in Papillary Reconstruction

Completed

NCT01305187Phase 4

Non-inferiority of Belotero® Basic Versus Juvéderm® Ultra 3

Completed

All 5 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 5